Depression and Anxiety Trial, Recruiting (NCT07464860)

Depression and Anxiety Trial, Recruiting NCT07464860 Sponsor: University of Arizona Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT07464860 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 65 years or older, of any sex, gender, or ethnic background
People who have a knee replacement surgery (not a revision of a previous knee replacement) scheduled within the next week to two months
People who report being in good general health, without conditions that could be affected by deep, controlled breathing — such as COPD, serious heart failure, complete heart block, glaucoma, or epilepsy
People without conditions that affect the body's cortisol (stress hormone) levels or that require steroid treatments — such as Cushing's syndrome, Addison's disease, pituitary tumours, adrenal gland tumours, or asthma
People without severe psychiatric or cognitive conditions that require a legal representative to make decisions on their behalf
People who are able to understand written and spoken English

Who may not be able to join:

People who are currently taking steroid medications in any form — including tablets, injections, nasal sprays, creams, or inhalers (for example: prednisone, hydrocortisone, dexamethasone, or similar medications)
People who do not have access to a smartphone, tablet, laptop, or desktop computer, or who do not have reliable internet access
People who experience serious surgical complications that require them to remain in hospital past the second day after surgery — such as needing a breathing machine, severe pain, severe nausea or vomiting, or signs of infection (this may affect the ability to continue in the trial after joining)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Devon E Cobos Garcia, PhD Candidate, University of Arizona

Phone: 904-477-7960

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07464860

Sponsor: University of Arizona

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: 904-477-7960

More information: https://clinicaltrials.gov/study/NCT07464860

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 65 years or older, of any sex, gender, or ethnic background
People who have a knee replacement surgery (not a revision of a previous knee replacement) scheduled within the next week to two months
People who report being in good general health, without conditions that could be affected by deep, controlled breathing — such as COPD, serious heart failure, complete heart block, glaucoma, or epilepsy
People without conditions that affect the body's cortisol (stress hormone) levels or that require steroid treatments — such as Cushing's syndrome, Addison's disease, pituitary tumours, adrenal gland tumours, or asthma
People without severe psychiatric or cognitive conditions that require a legal representative to make decisions on their behalf
People who are able to understand written and spoken English

Who may not be able to join:

People who are currently taking steroid medications in any form — including tablets, injections, nasal sprays, creams, or inhalers (for example: prednisone, hydrocortisone, dexamethasone, or similar medications)
People who do not have access to a smartphone, tablet, laptop, or desktop computer, or who do not have reliable internet access
People who experience serious surgical complications that require them to remain in hospital past the second day after surgery — such as needing a breathing machine, severe pain, severe nausea or vomiting, or signs of infection (this may affect the ability to continue in the trial after joining)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Arizona

Registry

ClinicalTrials.gov

Start date

1 July 2026

Est. completion

6 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Study Feasibility via Recruitment; Study Feasibility via Retention; Study Feasibility via Receipt of Saliva Samples; Study Feasibility via Postoperative Morbidity Survey Completion; Box Breathing Intervention Feasibility via Box Breathing Completion Survey; Box Breathing Intervention Feasibility via Feasibility of Intervention Measure (FIM); Box Breathing Intervention Acceptability via Acceptability of Intervention Measure (AIM); Box Breathing Intervention Appropriateness via Intervention Appropriateness Measure (IAM); TriPeaks Video Attention Control Task Feasibility via Attention Control Tas...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov